Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its proprietary drug discovery platform. This platform enables the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix’ value creation strategy is built around developing an internal pipeline of drug candidates and partnerships with the leading biopharmaceutical companies. Ribometrix is backed by a syndicate of blue-chip venture investors. 

Information Technology

Ribometrix

Allen Zhang

Katie Warner

Jessica Sorrentino

Orshi Kocsis

Jonathan Kearns

Murty Changalvala

Ramamurty Changalvala

Kevin Weeks

The Leadership Team at Ribometrix is responsible for setting the strategic direction and overall vision of the company, ensuring alignment between its innovative drug discovery platform and market opportunities. This team, comprising key executives like the CEO and VPs, oversees crucial functions such as operations, financial management, and scientific development in RNA biology, driving the internal pipeline of drug candidates and fostering partnerships with leading biopharmaceutical companies. Their collaborative efforts aim to advance Ribometrix's mission of developing novel therapeutics to address human diseases.

Leadership Team

Research and Development

Finance and Accounting

Leadership Team

About

Team members

Other teams at Ribometrix

Research and Development

Finance and Accounting